Cargando…

PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target

Hypofibrinolysis is a key abnormality in diabetes and contributes to the adverse vascular outcome in this population. Plasminogen activator inhibitor (PAI)-1 is an important regulator of the fibrinolytic process and levels of this antifibrinolytic protein are elevated in diabetes and insulin resista...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altalhi, Rawan, Pechlivani, Nikoletta, Ajjan, Ramzi A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003717/ https://www.ncbi.nlm.nih.gov/pubmed/33804680 http://dx.doi.org/10.3390/ijms22063170

Ejemplares similares

Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets
por: Pechlivani, Nikoletta, et al.
Publicado: (2018)

Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics
por: Pechlivani, Nikoletta, et al.
Publicado: (2021)

Plasmin Inhibitor in Health and Diabetes: Role of the Protein as a Therapeutic Target
por: Alsayejh, Basmah, et al.
Publicado: (2022)

Non-Traditional Pathways for Platelet Pathophysiology in Diabetes: Implications for Future Therapeutic Targets
por: Sagar, Rebecca C., et al.
Publicado: (2022)

Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk
por: Kearney, Katherine, et al.
Publicado: (2017)

Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges
por: Gaule, Thembaninkosi G., et al.
Publicado: (2021)

Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches
por: Gauer, Julia S., et al.
Publicado: (2022)

The Cellular and Protein Arms of Coagulation in Diabetes: Established and Potential Targets for the Reduction of Thrombotic Risk
por: Safdar, Nawaz Z., et al.
Publicado: (2023)

Diabetes and atherothrombosis: The circadian rhythm and role of melatonin in vascular protection
por: Otamas, Anastasia, et al.
Publicado: (2020)

Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets
por: Nian, Shen, et al.
Publicado: (2021)

Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
por: Toth-Manikowski, Stephanie, et al.
Publicado: (2015)

Metabolic Control in Type 1 Diabetes: Is Adjunctive Therapy the Way Forward?
por: Warnes, Harriet, et al.
Publicado: (2018)

Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date
por: Pearson, Sam, et al.
Publicado: (2019)

Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition
por: Sillen, Machteld, et al.
Publicado: (2020)

Understanding Bile Acid Signaling in Diabetes: From Pathophysiology to Therapeutic Targets
por: Ferrell, Jessica M., et al.
Publicado: (2019)

Role of Adropin in Cardiometabolic Disorders: From Pathophysiological Mechanisms to Therapeutic Target
por: Bozic, Josko, et al.
Publicado: (2021)

The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications
por: Ayola-Serrano, Nohora Cristina, et al.
Publicado: (2021)

Strategies for Therapeutic Amelioration of Aberrant Plasma Zn(2+) Handling in Thrombotic Disease: Targeting Fatty Acid/Serum Albumin-Mediated Effects
por: Regan-Smith, Spencer, et al.
Publicado: (2022)

Role of ACE and PAI-1 Polymorphisms in the Development and Progression of Diabetic Retinopathy
por: Saleem, Saba, et al.
Publicado: (2015)

Role of PAI-1 in hepatic steatosis and dyslipidemia
por: Levine, Joshua A., et al.
Publicado: (2021)

The TGF-β1/Upstream Stimulatory Factor-Regulated PAI-1 Gene: Potential Involvement and a Therapeutic Target in Alzheimer's Disease
por: Higgins, Paul J.
Publicado: (2006)

Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners
por: Ajjan, Ramzi, et al.
Publicado: (2019)

Pathophysiology and Emerging Molecular Therapeutic Targets in Heterotopic Ossification
por: Felix-Ilemhenbhio, Favour, et al.
Publicado: (2022)

Pathophysiology of Type 1 Diabetes and Gut Microbiota Role
por: Del Chierico, Federica, et al.
Publicado: (2022)

Therapeutic effects of calcium dobesilate on diabetic nephropathy mediated through reduction of expression of PAI-1
por: ZHANG, XIAOQIAN
Publicado: (2013)

PAI-1, the Plasminogen System, and Skeletal Muscle
por: Rahman, Fasih Ahmad, et al.
Publicado: (2020)

Stathmins and Motor Neuron Diseases: Pathophysiology and Therapeutic Targets
por: Gagliardi, Delia, et al.
Publicado: (2022)

Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial
por: Ajjan, Ramzi A, et al.
Publicado: (2019)

Small Molecule Targeting of PAI-1 Function: A New Therapeutic Approach for Treatment of Vascular Stenosis
por: Simone, Tessa M., et al.
Publicado: (2013)

Retroviral Elements in Pathophysiology and as Therapeutic Targets for Amyotrophic Lateral Sclerosis
por: Li, Wenxue, et al.
Publicado: (2022)

Pai syndrome: a review
por: Olivero, Francesca, et al.
Publicado: (2020)

PAI-1 and Diabetes: A Journey From the Bench to the Bedside
por: Schneider, David J., et al.
Publicado: (2012)

PAI-1: An Integrator of Cell Signaling and Migration
por: Czekay, Ralf-Peter, et al.
Publicado: (2011)

Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications
por: Lingegowda, Harshavardhan, et al.
Publicado: (2022)

Cystic Fibrosis–Related Diabetes: Pathophysiology and Therapeutic Challenges
por: Kelsey, Ryan, et al.
Publicado: (2019)

Neuroinflammation in Post-Traumatic Epilepsy: Pathophysiology and Tractable Therapeutic Targets
por: Sharma, Rishabh, et al.
Publicado: (2019)

SIRT6-PAI-1 axis is a promising therapeutic target in aging-related bone metabolic disruption
por: Aobulikasimu, Alkebaier, et al.
Publicado: (2023)

Effects of teneligliptin on PDMPs and PAI-1 in patients with diabetes on hemodialysis
por: Okuda, Yoshinori, et al.
Publicado: (2016)

Estimated glucose disposal rate demographics and clinical characteristics of young adults with type 1 diabetes mellitus: A cross-sectional pilot study
por: Nishtala, Revathi, et al.
Publicado: (2020)

Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies
por: Whitehead, Michael, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_517rno6f5vr52h7plv29d51q5g